<DOC>
	<DOCNO>NCT02054754</DOCNO>
	<brief_summary>The purpose study test safety observe pharmacokinetics ( distribution elimination drug ) compound dexanabinol ( ETS2101 ) healthy male subject follow single oral dose .</brief_summary>
	<brief_title>Assessment Single Doses Oral Dexanabinol Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>HU 211</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<criteria>Healthy male age 18 45 year Body mass index 18.0 32.0 kg/m2 , outside range , consider clinically significant investigator Participation clinical research study within previous 3 month Current smoker smoke within last 12 month History drug alcohol abuse past 2 year</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Dexanabinol</keyword>
	<keyword>Oral</keyword>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>